Vanguard FTSE Developed Markets ETF (VEA)
39.57
-0.40 -1.00%
NYSE Arca
Jul 7, 15:08
Delayed 2m
USD
Key Stats
| Expense Ratio | 0.05% |
| Total Assets Under Management | 112.66B |
| Share Class Assets Under Management | 71.97B |
| 30-Day Average Daily Volume | 13.75M |
| Net Asset Value | 39.96 |
| Discount or Premium to NAV | 0.03% |
| Turnover Ratio | 2.00% |
| 1 Year Fund Level Flows | 4.883B |
View All VEA News
News
-
WireHeadlineTime (ET)
-
SA Breaking News06/19 14:02
-
SA Breaking News03/20 04:39
-
SA Breaking News10/13 17:52
-
SA Breaking News09/22 18:21
-
SA Breaking News08/26 14:29
-
SA Breaking News01/21 09:23
-
SA Breaking News01/10 15:28
-
SA Breaking News10/23 11:53
-
SA Breaking News08/13 09:14
-
PR Newswire07/02 09:00
Performance & Returns
| Total Return (Price) | Total Return (NAV) | Cat. Total Return (NAV) | % Rank in Cat. (NAV) | |
|---|---|---|---|---|
| 1M | -0.49% | -0.59% | 2.06% | 67 |
| 3M | 19.77% | 19.81% | 20.68% | 39 |
| 6M | -8.35% | -8.35% | -10.38% | 54 |
| YTD | -8.41% | -8.27% | -9.70% | 54 |
| 1Y | -2.21% | -2.16% | -4.15% | 46 |
| 3Y | 2.02% | 2.01% | 0.76% | 45 |
| 5Y | 3.30% | 3.30% | 1.95% | 31 |
| 10Y | 6.14% | 6.09% | 5.41% | 20 |
| 15Y | -- | -- | 4.14% | -- |
| 20Y | -- | -- | 3.13% | -- |
Asset Allocation
| Type | % Net | % Long | % Short |
|---|---|---|---|
| Cash | 2.35% | 2.35% | 0.00% |
| Stock | 97.56% | 97.56% | 0.00% |
| Bond | 0.06% | 0.06% | 0.00% |
| Convertible | 0.00% | 0.00% | 0.00% |
| Preferred | 0.00% | 0.00% | 0.00% |
| Other | 0.03% | 0.03% | 0.00% |
Region Exposure
| Americas | 9.12% |
| North America | 9.11% |
| Latin America | 0.01% |
| Greater Europe | 52.92% |
| United Kingdom | 12.68% |
| Europe Developed | 39.14% |
| Europe Emerging | 0.56% |
| Africa/Middle East | 0.54% |
| Greater Asia | 37.96% |
| Japan | 23.71% |
| Australasia | 6.04% |
| Asia Developed | 7.84% |
| Asia Emerging | 0.37% |
| Market Classification | |
| % Developed Markets | 98.95% |
| % Emerging Markets | 1.05% |
Stock Sector Exposure
| Basic Materials | 8.01% |
| Communication Services | 6.01% |
| Consumer Cyclical | 9.92% |
| Consumer Defensive | 10.72% |
| Energy | 4.45% |
| Financial Services | 15.56% |
| Healthcare | 12.78% |
| Industrials | 15.04% |
| Real Estate | 3.53% |
| Technology | 10.31% |
| Utilities | 3.68% |
Stock Market Capitalization
| Giant | 37.57% |
| Large | 34.65% |
| Medium | 20.77% |
| Small | 6.22% |
| Micro | 0.79% |
Stock Style Exposure
| Large Cap Value | 28.23% |
| Large Cap Blend | 27.87% |
| Large Cap Growth | 16.43% |
| Mid Cap Value | 7.32% |
| Mid Cap Blend | 6.52% |
| Mid Cap Growth | 6.75% |
| Small Cap Value | 2.65% |
| Small Cap Blend | 2.21% |
| Small Cap Growth | 2.02% |
View More Holdings
As of May 31, 2020
Top 10 Holdings
| Symbol | Name | % Weight | Price | % Chg |
|---|---|---|---|---|
| NESN | Nestle SA | 1.82% | -- | -- |
| ROG | Roche Holding AG Dividend Right Cert. | 1.40% | -- | -- |
| NOVN | Novartis AG | 1.08% | -- | -- |
| 005930 | Samsung Electronics Co Ltd | 1.07% | -- | -- |
| 7203 | Toyota Motor Corp | 0.90% | -- | -- |
| AZN | AstraZeneca PLC | 0.82% | -- | -- |
| ASML | ASML Holding NV | 0.76% | -- | -- |
| SAP | SAP SE | 0.72% | -- | -- |
| NOVO B | Novo Nordisk A/S B | 0.63% | -- | -- |
| SAN | Sanofi SA | 0.62% | -- | -- |
Advertisement
Basic Info
| Investment Strategy | |
|---|---|
| The investment seeks to track the performance of the FTSE Developed All Cap ex US Index. The fund employs an indexing investment approach designed to track the performance of the FTSE Developed All Cap ex US Index, a market-capitalization-weighted index that is made up of approximately 3873 common stocks of large-, mid-, and small-cap companies located in Canada and the major markets of Europe and the Pacific region. The adviser attempts to replicate the target index by investing all, or substantially all, of its assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index. | |
| General | |
| Security Type | Exchange-Traded Fund |
| Equity Style | Large Cap/Blend |
| Fixed Income Style | -- |
| Broad Asset Class | International Equity |
| Broad Category | Equity |
| Category Name | Foreign Large Blend |
| Prospectus Objective | Foreign Stock |
| Fund Owner Firm Name | Vanguard |
| Benchmark Index | |
| FTSE Dvlp ex US All Cap(US RIC)NR USD | 100.0% |
| Reports | |
| One Page Report | Download |
Manager Info
| Name | Tenure |
|---|---|
| Christine Franquin | 7.36 yrs |
| Michael Perre | 2.59 yrs |
Net Fund Flows
| 1M | -1.035B |
| 3M | -1.887B |
| 6M | 1.468B |
| YTD | 1.468B |
| 1Y | 4.883B |
| 3Y | 28.82B |
| 5Y | 59.06B |
| 10Y | 85.17B |
Risk Info
| Beta (5Y) | 0.9667 |
| Max Drawdown (All) | 60.71% |
| Historical Sharpe Ratio (10Y) | 0.4175 |
| Historical Sortino (All) | 0.1157 |
| 30-Day Rolling Volatility | 25.83% |
| Daily Value at Risk (VaR) 1% (All) | 4.54% |
| Monthly Value at Risk (VaR) 1% (All) | 18.98% |
Fundamentals
| Dividend Yield TTM (7-7-20) | 2.64% |
| 30-Day SEC Yield | -- |
| 7-Day SEC Yield | -- |
| Weighted Average PE Ratio | 15.65 |
| Weighted Average Price to Sales Ratio | 0.9827 |
| Weighted Average Price to Book Ratio | 1.345 |
| Weighted Median ROE | 13.90% |
| Weighted Median ROA | 5.44% |
| Forecasted Dividend Yield | 3.79% |
| Forecasted PE Ratio | 17.06 |
| Forecasted Price to Sales Ratio | 0.9379 |
| Forecasted Price to Book Ratio | 1.277 |
| Number of Holdings | 3899 |
Growth Estimates
| Forecasted 5 Yr Earnings Growth | 9.09% |
| Forecasted Book Value Growth | 4.03% |
| Forecasted Cash Flow Growth | 4.44% |
| Forecasted Earnings Growth | 0.40% |
| Forecasted Revenue Growth | 2.03% |
Attributes
| Key Dates | |
|---|---|
| Inception Date | 7/20/2007 |
| Termination Date | |
| Last Annual Report Date | 12/31/2019 |
| Last Prospectus Date | 4/26/2019 |
| Attributes | |
| Exchange Traded Share | Yes |
| Exchange Traded Note | No |
| Enhanced Index Fund | No |
| Fixed Distribution Fund | No |
| High-Net Worth Individual Fund | No |
| Index Fund | Yes |
| Inverse Fund | No |
| Leveraged Fund | No |
| Fund of Funds | No |
| Currency Hedged Fund | No |
| Synthetic Replication Fund | No |
| Has Dividend Investment Plan | No |
| Socially Responsible Fund | No |
| General Availability | |
| Available for Insurance Product | No |
| Available for Retirement Plan | No |
| Available for RRSP | No |
Advertisement
